EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF); Scientific Opinion on Flavouring Group Evaluation 220, Revision 1 (FGE.220Rev1): alpha,beta-Unsaturated ketones and precursors from chemical subgroup 4.4 of FGE.19: 3(2H)-Furanones. by 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
General rights 
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners 
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. 
 
• Users may download and print one copy of any publication from the public portal for the purpose of private study or research. 
• You may not further distribute the material or use it for any profit-making activity or commercial gain 
• You may freely distribute the URL identifying the publication in the public portal  
 
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately 
and investigate your claim. 
   
 
Downloaded from orbit.dtu.dk on: Dec 18, 2017
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
(CEF); Scientific Opinion on Flavouring Group Evaluation 220, Revision 1
(FGE.220Rev1): alpha,beta-Unsaturated ketones and precursors from chemical
subgroup 4.4 of FGE.19: 3(2H)-Furanones.
EFSA Publication; Larsen, John Christian; Nørby, Karin Kristiane; Beltoft, Vibe Meister; Lund, Pia;
Binderup, Mona-Lise
Link to article, DOI:
10.2903/j.efsa.2011.1841
Publication date:
2011
Document Version
Publisher's PDF, also known as Version of record
Link back to DTU Orbit
Citation (APA):
EFSA Publication (2011). EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids
(CEF); Scientific Opinion on Flavouring Group Evaluation 220, Revision 1 (FGE.220Rev1): alpha,beta-
Unsaturated ketones and precursors from chemical subgroup 4.4 of FGE.19: 3(2H)-Furanones. European Food
Safety Authority.  (EFSA Journal; No. 1841). DOI: 10.2903/j.efsa.2011.1841
  EFSA Journal 2011; 9(3):1841
 
Suggested citation: EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids (CEF); Scientific 
Opinion on Flavouring Group Evaluation 220, Revision 1 (FGE.220Rev1): 
alpha,beta-Unsaturated ketones and precursors from chemical subgroup 4.4 of FGE.19:  
3(2H)-Furanones. EFSA Journal 2011; 9(3):1841. [26 pp.]. doi:10.2903/j.efsa.2011.1841. Available online: 
www.efsa.europa.eu/efsajournal.htm  
 
1 © European Food Safety Authority, 2011 
SCIENTIFIC OPINION  
Scientific Opinion on Flavouring Group Evaluation 220, Revision 1 
(FGE.220Rev1): 
alpha,beta-Unsaturated ketones and precursors from chemical subgroup 
4.4 of FGE.19:  
3(2H)-Furanones1 
EFSA Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
(CEF)2, 3  
Adopted on 30 September 2010 
SUMMARY  
The European Food Safety Authority (EFSA) asked the Panel on Food Contact Materials, Enzymes, 
Flavourings and Processing Aids (the Panel) to provide scientific advice to the Commission on the 
implications for human health of chemically defined flavouring substances used in or on foodstuffs in 
the Member States. In particular, the Panel was asked to evaluate flavouring substances using the 
Procedure as referred to in the Commission Regulation (EC) No 1565/2000.  
The present revision of FGE.220, FGE.220Rev1, concerns the evaluation of additional data submitted 
by Industry in response to the requested genotoxicity data in FGE.220 on the representative substance 
for subgroup 4.4b, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010]. 
Flavouring Group Evaluation 220 (FGE.220) concerns 10 substances, corresponding to subgroup 4.4 
of FGE.19. The 10 substances are alpha,beta-unsaturated 3(2H)-furanones [FL-no: 13.010, 13.084, 
13.085, 13.089, 13.099, 13.117, 13.119, 13.157, 13.175 and 13.176]. The substances were further 
subdivided into two subgroups as five of the 10 substances can only exist as alpha,beta-unsaturated 
                                                     
 
1  On request from the Commission, Question No EFSA-Q-2009-00568, adopted on 30 September 2010. 
2  Panel members Arturo Anadon, Mona-Lise Binderup, Wilfried Bursch, Laurence Castle, Riccardo Crebelli, Karl-Heinz 
Engel, Roland Franz, Nathalie Gontard, Thomas Haertle, Trine Husøy, Klaus-Dieter Jany, Catherine Leclercq, Jean 
Claude Lhuguenot, Wim Mennes, Maria Rosaria Milana, Karla Pfaff, Kettil Svensson, Fidel Toldra, Rosemary Waring, 
Detlef Wölfle. Correspondence: cef-unit@efsa.europa.eu  
3  Acknowledgement: The Panel wishes to thank the members of the Working Groups on Flavourings for the preparation of 
this Opinion: Ulla Beckman Sundh, Vibe Beltoft, Wilfried Bursch, Angelo Carere, Karl-Heinz Engel, Henrik Frandsen, 
Rainer Gürtler, Frances Hill, Trine Husøy, John Christian Larsen, Pia Lund, Wim Mennes, Gerard Mulder, Karin Nørby, 
Gerard Pascal, Iona Pratt, Gerrit Speijers, Harriet Wallin and EFSA’s staff member Kim Rygaard Nielsen for the 
preparatory work on this scientific Opinion. 
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ketones (subgroup 4.4a) while in the other five substances the alpha,beta double bond can be involved 
in keto-enol tautomerism (subgroup 4.4b). 
For the substances in subgroup 4.4a [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175], the previous 
conclusions of the Panel in FGE.220 were that the available data on genotoxicity were too limited to 
evaluate these substances through the Procedure. Additional studies were needed as outlined in the 
Genotoxicity Test Strategy for Substances belonging to Subgroups of FGE.19 (EFSA, 2008bb). 
For the substances in subgroup 4.4b [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176], the Panel 
had in FGE.220 expressed the view that evidence for genotoxicity was available both in vitro and in 
vivo. Evidence from in vitro studies indicated that the genotoxicity of the candidate substances in this 
subgroup may be caused by indirect (thresholded) mechanisms of action (in particular generation of 
reactive oxygen species). The concern for carcinogenicity was alleviated, since one of the substances, 
for which positive genotoxicity data in mice were obtained, was not carcinogenic in a valid chronic 
assay in rats. Therefore, no further genotoxicity tests in somatic cells were required. However, some 
evidence was also available that this substance might elicit genotoxic effects in germ cells, which 
theoretically may result in reduced reproductive capacity or in inheritable genetic damage. Reduced 
reproductive capacity and inheritable genetic damage are toxicological endpoints which differ from 
carcinogenicity and therefore, the negative results for the carcinogenicity study could not be used to 
overrule this concern. It is not clear if (and if so to what extent) the thresholded mechanism mentioned 
above would be relevant for genotoxic effects in the germ cells. Therefore, the Panel conclusions of 
the previous evaluation in FGE.220 were that these five substances could not be evaluated through the 
Procedure. 
The Panel recognised that the studies which provided indications for germ cell genotoxicity were of 
limited validity. For this reason a robust GLP-controlled cytogenetic investigation in mouse 
spermatocytes according to the OECD guideline 483 was requested. 
In March 2009 the Flavouring Industry submitted new data in reply to the above requested data for 
subgroup 4.4b of FGE.220. These data have now been examined by the Panel which has concluded the 
following. The results of a valid rat fertility and dominant lethal study have shown that the 
representative substance for subgroup 4.4b, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010], 
is unable to induce adverse effects both on male rat reproductive capacity and dominant lethality. On 
this basis, the Panel concludes that there is no concern for this substance  to induce heritable genetic 
damage or adverse effects on male reproductive capacity. Accordingly the substances in subgroup 
4.4b of FGE.19 [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176] can be evaluated using the 
Procedure.  
Since no data were submitted to further evaluate the genotoxic potential of the substances in subgroup 
4.4a, the Panel maintains its position that for this subgroup additional data on genotoxicity are needed. 
© European Food Safety Authority, 2011 
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BACKGROUND 
Regulation (EC) No 2232/96 of the European Parliament and the Council (EC, 1996a) lays down a 
Procedure for the establishment of a list of flavouring substances the use of which will be authorised 
to the exclusion of all other substances in the EU. In application of that Regulation, a Register of 
flavouring substances used in or on foodstuffs in the Member States was adopted by Commission 
Decision 1999/217/EC (EC, 1999a), as last amended by Commission Decision 2009/163/EC (EC, 
2009a). Each flavouring substance is attributed a FLAVIS-number (FL-number) and all substances are 
divided into 34 chemical groups. Substances within a group should have some metabolic and 
biological behaviours in common. 
Substances which are listed in the Register are to be evaluated according to the evaluation programme 
laid down in Commission Regulation (EC) No 1565/2000 (EC, 2000a), which is broadly based on the 
Opinion of the Scientific Committee on Food (SCF, 1999a). For the submission of data by the 
manufacturer, deadlines have been established by Commission Regulation (EC) No 622/2002 (EC, 
2002b).  
After the completion of the evaluation programme the Union list of flavouring substances for use in or 
on foods in the EU shall be adopted (Article 5 (1) of Regulation (EC) No 2232/96) (EC, 1996a). 
Flavouring Group Evaluation 19 (FGE.19) contains 360 flavouring substances from the EU Register 
being alpha,beta-unsaturated aldehydes or ketones and precursors which could give rise to such 
carbonyl substances via hydrolysis and/or oxidation (EFSA, 2008b). 
The alpha,beta-unsaturated aldehyde and ketone structures were considered by the Panel to be  
structural alerts for genotoxicity. The Panel noted that there were limited genotoxicity data on these 
flavouring substances but that positive genotoxicity studies were identified for some substances in the 
group. 
The alpha,beta-unsaturated carbonyls were subdivided into 28 subgroups on the basis of structural 
similarity (EFSA, 2008b). In an attempt to decide which of the substances could go through the 
Procedure, a (quantitative) structure-activity relationship (Q)SAR prediction of the genotoxicity of 
these substances was undertaken considering a number of models (DEREKfW, TOPKAT, DTU-NFI-
MultiCASE Models and ISS-Local Models (Gry et al., 2007)). 
The Panel noted that for most of these models internal and external validation has been performed, but 
considered that the outcome of these validations was not always extensive enough to appreciate the 
validity of the predictions of these models for these alpha,beta-unsaturated carbonyls. Therefore, the 
Panel considered it inappropriate to totally rely on (Q)SAR predictions at this point in time and 
decided not to take substances through the Procedure based on negative (Q)SAR predictions only. 
The Panel took note of the (Q)SAR predictions by using two ISS Local Models (Benigni & Netzeva, 
2007a; Benigni & Netzeva, 2007b) and four DTU-NFI MultiCASE Models (Gry et al., 2007; Nikolov 
et al., 2007) and the fact that there are available data on genotoxicity in vitro and in vivo, as well as 
data on carcinogenicity for several substances. The Panel decided that 11 subgroups (1.1.2, 1.1.3, 
1.1.4, 2.4, 2.6, 2.7, 3.1, 3.3, 4.1, 4.2 and 4.4) (EFSA, 2008b) should be further examined to determine 
whether evaluation through the Procedure is feasible. Corresponding to these 11 subgroups, 11 
Flavouring Group Evaluations (FGEs) were established (FGE.201, 202, 203, 210, 212, 213, 214, 216, 
217, 218 and 220). If the Panel concludes for any substances in these 11 FGEs that they cannot be 
evaluated using the Procedure then it has to be decided if there is a safety concern for certain 
substances or if additional data are required in order to finalise the evaluation. If the Panel concludes 
that a genotoxic potential can be ruled out for the substances, they will be merged with structurally 
related substances in other FGEs and evaluated using the Procedure. 
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TERMS OF REFERENCE 
The European Food Safety Authority (EFSA) is requested to carry out a risk assessment on flavouring 
substances in the Register prior to their authorisation and inclusion in a Union List according to 
Commission Regulation (EC) No 1565/2000 (EC, 2000a).  
In addition, in letter of 29 April 2009, “The European Commission requests the European Food Safety 
Authority to carry out a risk assessment on 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] 
and on substances of sub-group 4.4b covered by  [FL-no: 13.010] as representative substance, as stated 
in “List of alpha,beta-Unsaturated Aldehydes and Ketones representative of FGE.19 substances for 
Genotoxicity Testing” (Opinion adopted 26 March 2009) and in FGE.220 (minutes of CEF Panel 4th 
Plenary, 26-29 January 2009), in accordance with Commission Regulation (EC) No 1565/2000, if 
possible by the end of the evaluation programme, if not, within nine month from the finalisation of 
that programme”. The deadline of the Terms of Reference was negotiated to 30 September 2010.  
HISTORY OF THE EVALUATION OF THE SUBSTANCES IN THE PRESENT FGE 
EFSA considered in FGE.220 subgroup 4.4 of FGE.19. Subgroup 4.4 consists of 10 alpha,beta-
unsaturated 3(2H)-furanones, which have been further subdivided into two groups 4.4a and 4.4b based 
on chemical structures (Table 1). For both groups the Panel concluded that the genotoxicity alert could 
not be ruled out based on data available at that time, and accordingly additional genotoxicity data were 
requested for both groups. The additional information should be based on specific data requested in 
FGE.220 and performed on representative substances selected from both groups (EFSA, 2008bb). 
 
FGE Adopted by 
EFSA 
Link No. of 
Substances 
FGE.220 29 January 2009 http://www.efsa.europa.eu/EFSA/efsa_locale-
1178620753812_1211902503180.htm
10 
FGE.220Rev1 30 September 
2010 
 10 
 
Representatives selected by EFSA for Subgroup 4.4 of FGE.220 (EFSA, 2008bb) 
Subgroup FL-no Register name for representatives Structural formula 
4.4a 13.157 5-Methylfuran-3(2H)-one O
O  
13.175 4-Acetyl-2,5-dimethylfuran-3(2H)-one O
O
O  
4.4b 13.010 4-hydroxy-2,5-dimethylfuran-3(2H)-one O
OHO  
 
The present revision of FGE.220, FGE.220Rev1, concerns the evaluation of additional data submitted 
by Industry in response to the requested genotoxicity data in FGE.220 on the representative substance 
for subgroup 4.4b, 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010]. These new data are 
described and evaluated in Section 4 in the present version of FGE.220Rev1. Sections 1-3 report the 
same information that was present in the earlier version of FGE.220. Additional data on subgroup 4.4a 
have not been submitted by Industry yet. 
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ASSESSMENT 
1. Presentation of the Substances in Flavouring Group Evaluation 220 
1.1. Description 
The present Flavouring Group Evaluation 220 (FGE.220) concerns 10 substances, which are presented 
in Table 1. The 10 substances correspond to subgroup 4.4 of FGE.19 (EFSA, 2008b). These 
substances are all alpha,beta-unsaturated 3(2H)-furanones [FL-no: 13.010, 13.084, 13.085, 13.089, 
13.099, 13.117, 13.119, 13.157, 13.175 and 13.176]. Five of the 10 substances can only exist as 
ketones [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175] (subgroup 4.4a). In the remaining five 
substances, the alpha,beta double bond can be involved in keto-enol tautomerism as such [FL-no: 
13.010, 13.084 and 13.085] or after hydrolysis of the ester moiety [13.099 and 13.176] (subgroup 
4.4b).  
In subgroup 4.4a, two substances possess alkoxy groups as side chains [FL-no: 13.089 and 13.117], 
two are mono- and di-methylated furanones [FL-no: 13.119 and 13.157] and one is a di-methylated 
furanone with an additional acetyl group as substituent [FL-no: 13.175].  
A summary of the current evaluation status of both subgroups 4.4a and 4.4b by the JECFA is given in 
Table 2 (JECFA, 2006a). 
The alpha,beta-unsaturated aldehyde and ketone structures are considered by the Panel to be structural 
alerts for genotoxicity (EFSA, 2008b). Accordingly the available data on genotoxic or carcinogenic 
activity for the ten ketones in FGE.220 were considered in this FGE. 
The Panel has also taken into consideration the outcome of the predictions from five selected (Q)SAR 
models (Benigni & Netzeva, 2007a; Gry et al., 2007; Nikolov et al., 2007) on the ketones in the 
present FGE. The 10 alpha,beta-unsaturated ketones and their (Q)SAR predictions are shown in Table 
3. 
2. Toxicity 
2.1. (Q)SAR Predictions 
In Table 3 the outcomes of the (Q)SAR predictions for possible genotoxic activity in five in vitro 
(Q)SAR models (ISS Local Model-Ames test, DTU-NFI MultiCASE-Ames test, -Chromosomal 
aberration test in Chinese hamster ovary cells (CHO), -Chromosomal aberration test in Chinese 
hamster lung cells (CHL), and -Mouse lymphoma test) are presented. 
For none of the candidate substances in this FGE a prediction was obtained with the ISS Local Model 
for gene mutations in Salmonella TA100, as all substances were out of domain. The DTU-NFI 
MultiCase models for mutagenicity predicted negative (no genotoxic potential) in the Ames test for all 
10 substances, and also for three substances (all three in subgroup 4.4b) in the Mouse lymphoma 
assay. For one substance [FL-no: 13.157] from subgroup 4.4a, a positive response in this assay was 
predicted. The other candidate substances were out of domain. All but four substances were out of 
domain for both the Chromosomal aberration CHO and CHL models. Four substances from subgroup 
4.4b were in the domain of the Chromosomal aberrations CHL model and for these four the 
application of the model resulted in a negative prediction. 
It is concluded that these models, except for the negative predictions for the substance in the DTU-NFI 
MultiCASE model for Ames test, do not seem to generate a reliable and reproducible pattern of 
predictions for this group. Negative predictions in mammalian cells were only available for four of the 
substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta double bond can be involved 
Flavouring Group Evaluation 220Rev1
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in keto-enol tautomerism). One positive prediction was available for genotoxic activity in mammalian 
cells for a substance in subgroup 4.4a (Furan-3(2H)-ones). 
2.2. Carcinogenicity Studies 
A carcinogenicity study with chronic exposure is available for one substance in subgroup 4.4b. 
In an OECD Guideline 451- and GLP-compliant study, groups of 60 male and 60 female Sprague-
Dawley rats were fed diets containing 0 (controls), 100, 200 or 400 mg 4-hydroxy-2,5-dimethylfuran-
3(2H)-one [FL-no: 13.010] per kg body weight (bw)/day for two years. Mean body weights and body 
weight gains of male and female rats exposed to 400 mg 4-hydroxy-2,5-dimethyl-3(2H)-furanone/kg 
bw/day were decreased compared to those of the controls in the last part of the study. No neoplasms or 
non-neoplastic lesions were attributed to exposure to 4-hydroxy-5-dimethyl-3(2H)-furanone. The 
NOAEL was 200 mg/kg bw/day (Kelly & Bolte, 2003). 
The Panel concluded that the study on 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] was 
valid and did not show a carcinogenic potential in rats. 
Study validation and results are presented in Table 4. 
2.3. Genotoxicity Studies 
Studies are available for four of the candidate substances in FGE.220, as summarised in Tables 5 and 
6. 
Subgroup 4.4a (Furan-3(2H)-ones) 
For one substance in subgroup 4.4a (2,5-dimethyl-3(2H)-furanone [FL-no: 13.119]) no mutagenic 
activity was observed in S. typhimurium in a valid assay. No experimental data were available for any 
of the other substances in this subgroup. 
Subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta double bond can be involved in keto-enol 
tautomerism) 
For three substances, which belong to subgroup 4.4b, the following results have been reported: 
4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] 
For 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] publications on in vitro and in vivo 
studies are available. In three studies the potential of the test substance to induce gene mutations in S. 
Typhimurium was studied. The substance was found positive in two valid studies and in one study 
with limited validity. The substance did not cause gene mutations in a valid study in Escherichia coli 
WP2 uvrA-. It was also observed that the substance caused DNA repair in a less relevant bacterial test 
and single strand breaks in purified DNA. 
All in vivo studies provided indications for a genotoxic potential. Two studies showing micronucleus 
formation in peripheral blood cells were considered valid (Hiramoto et al., 1996b; Hiramoto et al., 
1998); in a third study similar evidence, but of limited validity, was obtained (Xing et al., 1988). The 
latter authors also reported an increase in sister chromatid exchanges (SCE) in mouse bone marrow, 
but the validity of that observation could not be assessed. In addition this endpoint is of questionable 
relevance for the assessment of genotoxicity. 
In addition to the genotoxicity observed in somatic cells, three studies provided evidence for 
genotoxicity in germ cells.  
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The evidence of chromosome aberration induction in mouse germ cells provided in the study by Xing 
et al. (1988) is poor because it is essentially based on an increase of premature disjunction of sex 
chromosomes and autosomes at metaphase I. This effect could be considered at most an alert of 
possible subsequent missegregation events; even so, data have been published (Liang & Pacchierotti, 
1988) showing the lack of correlation between univalents at metaphase I and aneuploidy at metaphase 
II.  
Tian et al. (1992) reported an induction of SCE in spermatogonia. Incomplete information is given on 
the experimental protocol. There is a dose-dependent increase of SCE/cell, with each dose group 
significantly higher than the negative control. For these reasons, these data seem to be convincing 
although obtained on a small (3) number of animals/group. The relevance of SCE in spermatogonia as 
an indicator of heritable genetic damage is limited. 
In the same paper Tian et al. (Tian et al., 1992) reported the induction of micronuclei in early sperm 
cells. This test measures the induction of DNA lesions in preleptotene spermatocytes that can lead to 
breaks and fragments several days later, at the first or second meiotic division. The test has not been 
standardised and validated for routine regulatory application, but has been conducted by more than 
one laboratory in the world with consistent results. The study seems adequately performed. Staining 
with Giemsa is not optimal and does not allow to distinguish among phases of spermatid 
differentiation as recommended by the guidelines (Russo, 2000). However, this drawback could hardly 
produce an overestimation of the effect, more likely, if any, an underestimation. 
4-Hydroxy-5-methylfuran-3(2H)-one [FL-no: 13.085] and 2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone [FL-no: 13.084] 
Reverse mutations were also observed in S. typhimurium TA100, but not TA98 with 4-hydroxy-5-
methylfuran-3(2H)-one [FL-no: 13.085] and with 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-
no: 13.084]. The other strains were not tested. The same substances could induce single strand breaks 
in purified DNA. With 2-ethyl-4-hydroxy-5-methyl-3(2H)-furanone [FL-no: 13.084] also induction of 
micronuclei in peripheral erythrocytes was observed in two valid in vivo assays. 
Mechanistic data 
For the substances in subgroup 4.4b also mechanistic studies were carried out with [FL-no: 13.010, 
13.084 and 13.085], all of which were considered valid. These substances were identified as Maillard 
reaction products in soy sauce. When the substance [FL-no: 13.085] was incubated with supercoiled 
pBR 322 plasmid DNA, single strand breaks were observed at pH 4.4, but not at pH 7.4. When a spin 
trap was also present, formation of hydroxy radicals together with a carbon-centered radical could be 
demonstrated. Subsequent addition of superoxide dismutase and catalase inhibited the DNA breaking 
showing involvement of hydrogen peroxide. Potassium iodide, mannitol, sodium azide and ethanol 
were also inhibitory to the DNA breaking showing involvement of hydroxy radicals. Spin trapping 
agents and thiol compounds and metal chelators also effectively inhibited the breaking of DNA 
(Hiramoto et al., 1996a). Similar studies were carried out with [FL-no: 13.010 and 13.084] with the 
same results and it was also demonstrated that these substances are capable to reduce Fe3+ at neutral or 
alkaline pH (Li et al., 1998).  
 Study results and comments on study validity are presented in Table 5 and 6. 
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2.4. Conclusion on Genotoxicity and Carcinogenicity – Text taken from FGE.2204 (EFSA, 
2009ae) 
Apart from the negative predictions for the substances in the DTU-NFI MultiCASE model for the 
Ames test, the (Q)SAR models do not seem to generate a reliable and reproducible pattern of 
predictions on the genotoxicity for the substances in this FGE.  
For one substance in subgroup 4.4a (2,5-dimethyl-3(2H)-furanone [FL-no: 13.119]) no mutagenic 
activity was observed in S. typhimurium in a valid assay. This study result is insufficient to reach a 
conclusion as to the (absence) of genotoxicity for this subgroup. 
With several substances in subgroup 4.4b indications have been obtained in in vitro studies that the 
genetic damage they cause is related to the generation of reactive oxygen species as a result of redox 
cycling in combination with metal ions present in the media. The valid positive in vivo data were 
obtained with high dose levels that may be anticipated to have exhausted the anti-oxidant capacity of 
the target cells. This, in combination with the absence of carcinogenicity observed in a valid 
carcinogenicity study in rats with one of the substances [FL-no: 13.010], which was tested positive in 
the genotoxicity assays, takes away a concern for genotoxic events resulting in carcinogenicity in 
somatic cells. 
For two of the studies in which genotoxic effects were observed in germ cells in vivo the studies had 
limited validity and/or address endpoints that may have limited relevance for the assessment of 
genotoxic potential. The Panel noted that a positive result was obtained in a micronucleus study in 
early sperm cells. However, a micronucleus test does not discriminate between aneuploidy and 
chromosomal breakage. The observed effects in the germ cells could be the result of the 
malsegregation of chromosomes which is generally considered a thresholded event. They may 
alternatively be the result of the (thresholded) generation of reactive oxygen species. 
3. Conclusions – Text taken from FGE.2205 (EFSA, 2009ae) 
For the substances in subgroup 4.4a [FL-no: 13.089, 13.117, 13.119, 13.157 and 13.175], the Panel 
considered that presently the available data on genotoxicity are too limited to evaluate these 
substances through the Procedure. Additional studies are needed as outlined in the Genotoxicity Test 
Strategy for Substances belonging to Subgroups of FGE.19 (EFSA, 2008bb). 
For the substances in subgroup 4.4b [FL-no: 13.010, 13.084, 13.085, 13.099 and 13.176], evidence for 
genotoxicity was obtained in vitro and in vivo. Evidence is available from in vitro studies that the 
genotoxicity of the candidate substances in this subgroup may be caused by indirect (thresholded) 
mechanisms of action (in particular generation of reactive oxygen species). The concern for 
carcinogenicity is alleviated, since one of the substances, for which positive genotoxicity data in mice 
were obtained, was not carcinogenic in a valid chronic assay in rats. Therefore, no further genotoxicity 
tests in somatic cells are required. However, some evidence was also available that this substance 
might elicit genotoxic effects in germ cells, which theoretically may result in reduced reproductive 
capacity or in inheritable genetic damage. Reduced reproductive capacity and inheritable genetic 
damage are toxicological endpoints which differ from carcinogenicity and therefore, the negative 
results for the carcinogenicity study cannot be used to overrule this concern. Also it is not clear if (and 
if so to what extent) the thresholded mechanism mentioned above would be relevant for genotoxic 
effects in the germ cells. Therefore, the Panel concluded that presently these five substances cannot be 
evaluated through the Procedure. 
                                                     
 
4 The conclusion in Section 2.4 is cited from the previous version of the present FGE, FGE.220. This conclusion 
is the basis for the request of additional genotoxicitydata in FGE.220. 
5 The conclusion in Section 3 is cited from the previous version of the present FGE, FGE.220. This conclusion is 
the basis for the request of additional genotoxicitydata in FGE.220. 
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The Panel recognised that the studies which provided indications for germ cell genotoxicity are of 
limited validity. For that reason a robust GLP-controlled cytogenetic investigation in mouse 
spermatocytes according to the OECD Guideline 483 is requested. 
4. Additional data submitted by Industry 
In response to the EFSA request in FGE.220, of a cytogenetic study in mouse spermatocytes (OECD 
TG 483), Industry has submitted the following data: 
 
• 2-Year carcinogenicity bioassay in rats with a substance coded  ST 07 C99 (this is the 
study on [FL-no: 13.010] by Kelly & Bolte, 2003); 
• Oral male fertility study of FURANEOL =  4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-
no: 13.010] (test article code ST17C07) in rats (Sloter, 2008); 
• Oral micronucleus assay in bone marrow cells of the mouse with NEOFURANEOL (no 
identification of this substance is available) (Honarvar, 2008b); 
• Mouse lymphoma (TK) specific locus mutation assay with compound 0478/1 (Ross & 
Harris, 1979a). 
 
4.1. Evaluation of Additional Data 
The Panel noted that among the studies submitted by Industry only the rat fertility study, which 
includes also the analysis of dominant lethals, is considered relevant for the specific EFSA request. 
The 2-year carcinogenicity bioassay in rats by Kelly and Bolte (Kelly & Bolte, 2003) was already 
evaluated by the Panel in the previous version of this FGE (Section 2.2 (Table 4)). It was considered 
as a valid, negative study, however not relevant for the evaluation of possibly inheritable damage. 
Also the mouse bone marrow micronucleus assay with neofuraneol (Honarvar, 2008b) and the in vitro 
mouse lymphoma TK assay (Ross & Harris, 1979a) are considered not relevant to clear the concern 
for possible inheritable damage. Furthermore, an adequate identification of the test substance 
Neofuraneol was not possible, due to incomplete reporting. For these reasons these three studies will 
not be further considered in this section. 
Oral Male Fertility Study of 4-Hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] in Rats (Sloter, 
2008) 
The objective of this study, performed according to ICH Guideline 4.1.1 (ICH, 2006) under GLP, was 
to determine the potential effects of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] on 
mating, fertility and gonadal function in male rats with two separate mating trials. 4-Hydroxy-2,5-
dimethylfuran-3(2H)-one was administered by gavage once daily to three groups of 25 male 
Crl:CD(SD) rats. Dosage levels were 100, 500 and 1000 mg/kg bw/day. A concurrent control group of 
25 males received the vehicle (propylene glycol) on a comparable regimen. The first mating (Phase I), 
following 2 weeks of male administration, using untreated females, was conducted to detect potential 
elicitation of early genotoxic effects on the embryo with reduced risk of test-article related deficiencies 
in mating or fertility. The second mating (Phase II), following 9 weeks of male dose administration, 
was conducted following male exposure throughout a complete spermatogenic cycle using a second 
set of untreated females.   
There was no test-article related mortality noted in this study. A slightly lower mean body-weight gain 
was noted in the 1000 mg/kg/day group when evaluated for the overall treatment period. No test-
article related effects on male reproductive performance were observed at 100, 500 and 1000 
mg/kg/day when males were mated with Phase I or Phase II females. In particular, there were no 
effects on spermatogenic endpoints (mean testicular and epididymal sperm numbers, sperm production 
rate, motility and morphology, reproductive organs or macroscopic findings) at any of the doses 
tested. The mean percentage of sperm with abnormal morphology (separated head and flagellum) was 
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slightly higher in the 500 and 1000 mg/kg/day groups; however, this was primarily attributed to a 
single male in the respective groups and therefore not considered test-article related. The number of 
females mated and the number of pregnant females was comparable to controls. Uterine examination 
was performed for both Phase I and Phase II females. The analysis of embryonic data (corpora lutea, 
implantation sites, viable embryos, dead embryos, early resorptions, late resorptions, total resorptions, 
post- and pre-implantation losses) did not reveal dominant lethal effects. The study does not indicate a 
potential of 4-hydroxy-2,5-dimethylfuran-3(2H)-one [FL-no: 13.010] to affect male fertility. This 
study can be considered to be equivalent to an OECD 478 Dominant Lethal assay. The Dominant 
Lethal assay has been recommended as a follow-up study in case of positive results in the OECD TG 
483 (Eastmond et al., 2009). On this basis the Panel considers it acceptable to substitute the requested 
study according to OECD Guideline 483 with the Dominant Lethal test. 
Study results and comments on study validity are presented in Table 7. 
4.2. Conclusion on Additional Data 
The results of a valid rat fertility and dominant lethal study have shown that 4-hydroxy-2,5-
dimethylfuran-3(2H)-one is unable to induce both adverse effects on male rat reproductive capacity 
and dominant lethality. On this basis the Panel concludes that for this substance there is no concern for 
its potential to induce heritable genetic damage or adverse effects on male reproductive capacity. 
Accordingly the substances in subgroup 4.4b of FGE.19 [FL-no: 13.010, 13.084, 13.085, 13.099 and 
13.176] can be evaluated using the Procedure. Since no data were submitted to further evaluate the 
genotoxic potential of the substances in subgroup 4.4a, the Panel maintains its position that for this 
subgroup additional data on genotoxicity are needed. 
 
Flavouring Group Evaluation 220Rev1
 
 
12 
 
EFSA Journal 2011; 9(3):1841 
TABLE 1: SPECIFICATION SUMMARY OF THE SUBSTANCES IN THE FLAVOURING GROUP EVALUATION 220 (JECFA, 2006A) 
Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 220 (JECFA, 2006a) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
Substances in subgroup 4.4a (Furan-3(2H)-ones) 
13.089 
1451 
2,5-Dimethyl-4-methoxyfuran-3(2H)-one O
OO
3664 
 
4077-47-8 
Liquid 
C7H10O3 
142.15 
Insoluble 
Soluble 
61-63 (0.4 hPa) 
 
NMR 
97 % 
1.475-1.481 
1.091-1.097 
13.117 
 
2,5-Dimethyl-4-ethoxyfuran-3(2H)-one O
OO
 
 
65330-49-6 
Solid 
C8H12O3 
156.18 
 
1 ml in 1 ml 
251 
60 
 
95 % 
n.a. 
n.a. 
13.119 
 
2,5-Dimethylfuran-3(2H)-one O
O
 
11066 
14400-67-0 
Liquid 
C6H8O2 
112.13 
 
1 ml in 1 ml 
68 (16 hPa) 
 
 
95 % 
1.473-1.479 
1.050-1.060 
13.157 
 
5-Methylfuran-3(2H)-one O
O
 
 
3511-32-8 
Liquid 
C5H6O2 
98.10 
 
1 ml in 1 ml 
59 (13 hPa) 
 
 
95 % 
1.492-1.498 
 
13.175 
 
4-Acetyl-2,5-dimethylfuran-3(2H)-one O
O
O
 
 
 
Solid 
C8H10O3 
154.17 
 
1 ml in 1 ml 
283 
34 
 
95 % 
n.a. 
n.a. 
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism) 
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Table 1: Specification Summary of the Substances in the Flavouring Group Evaluation 220 (JECFA, 2006a) 
FL-no 
JECFA-
no 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
Phys.form 
Mol.formula 
Mol.weight 
Solubility 1) 
Solubility in ethanol 2) 
Boiling point, °C 3) 
Melting point, °C 
ID test 
Assay minimum 
Refrac. Index 4) 
Spec.gravity 5) 
13.010 
1446 
4-Hydroxy-2,5-dimethylfuran-3(2H)-one O
OHO
3174 
536 
3658-77-3 
Solid 
C6H8O3 
128.13 
Insoluble 
Soluble 
n.a. 
78-80 
IR 
98 % 
n.a. 
n.a. 
13.084 
1449 
2-Ethyl-4-hydroxy-5-methyl-3(2H)-furanone O
OHO
3623 
 
27538-09-6 
Liquid 
C7H10O3 
142.15 
Soluble 
Soluble 
103 (20 hPa) 
 
NMR 
96 % 
1.509-1.514 
1.133-1.143 
13.085 
1450 
4-Hydroxy-5-methylfuran-3(2H)-one O
OHO
3635 
11785 
19322-27-1 
Solid 
C5H6O3 
114.10 
Soluble 
Soluble 
n.a. 
126-133 
NMR 
97 % 
n.a. 
n.a. 
13.099 
1456 
4-Acetoxy-2,5-dimethylfuran-3(2H)-one O
OO
O
3797 
 
4166-20-5 
Liquid 
C8H10O4 
170.17 
Slightly soluble 
Soluble 
243 
 
NMR 
85 % 
1.476-1.480 
1.159-1.167 
13.176 
1519 
Furaneyl butyrate O
OO
O
3970 
 
 
Liquid 
C10H14O4 
198.22 
Insoluble 
Soluble 
287 
 
NMR 
93 % 
1.467-1.473 
1.095-1.103 
1) Solubility in water, if not otherwise stated. 
2) Solubility in 95 %  ethanol, if not otherwise stated. 
3) At 1013.25 hPa, if not otherwise stated. 
4) At 20°C, if not otherwise stated. 
5) At 25°C, if not otherwise stated. 
n.a.: not applicable. 
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TABLE 2: SUMMARY OF SAFETY EVALUATION APPLYING THE PROCEDURE (BASED ON INTAKES CALCULATED BY THE MSDI APPROACH)  
Table 2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) (JECFA, 2006a) 
FL-no 
JECFA-no 
EU Register name Structural formula MSDI 1)  (μg/capita/day) 
EU 
USA 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named compound  
[4) or 5)] 
Substances in subgroup 4.4a (Furan-3(2H)-ones) 
13.089 
1451 
2,5-Dimethyl-4-methoxyfuran-3(2H)-one O
OO
12 
0.7 
Class II 
A3: Intake below threshold 
4) 
13.117 
 
2,5-Dimethyl-4-ethoxyfuran-3(2H)-one O
OO
0.018 
 
 Not evaluated by JECFA 
13.119 
 
2,5-Dimethylfuran-3(2H)-one O
O
1.9 
 
 Not evaluated by JECFA 
13.157 
 
5-Methylfuran-3(2H)-one O
O
0.0061 
 
 Not evaluated by JECFA 
13.175 
 
4-Acetyl-2,5-dimethylfuran-3(2H)-one O
O
O
1.3 
 
 Not evaluated by JECFA 
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism) 
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Table 2: Summary of Safety Evaluation Applying the Procedure (based on intakes calculated by the MSDI approach) (JECFA, 2006a) 
FL-no 
JECFA-no 
EU Register name Structural formula MSDI 1)  (μg/capita/day) 
EU 
USA 
Class 2) 
Evaluation procedure path 3) 
Outcome on the named compound  
[4) or 5)] 
13.010 
1446 
4-Hydroxy-2,5-dimethylfuran-3(2H)-one O
OHO
4483 
5203 
Class II 
A3: Intake above threshold, A4: 
Not endogenous, A5: Adequate 
NOAEL exists 
4) 
13.084 
1449 
2-Ethyl-4-hydroxy-5-methyl-3(2H)-furanone O
OHO
203 
13 
Class II 
A3: Intake below threshold 
4) 
13.085 
1450 
4-Hydroxy-5-methylfuran-3(2H)-one O
OHO
47.8 
0.07 
Class II 
A3: Intake below threshold 
4) 
13.099 
1456 
4-Acetoxy-2,5-dimethylfuran-3(2H)-one O
OO
O
ND 
8 
Class II 
A3: Intake below threshold 
4) 
13.176 
1519 
Furaneyl butyrate O
OO
O
 
 
 
 
Evaluation deferred by JECFA 
1) EU MSDI: Amount added to food as flavour in (kg / year) x 10E9 / (0.1 x population in Europe (= 375 x 10E6) x 0.6 x 365)  =  µg/capita/day. 
2) Thresholds of concern: Class I = 1800, Class II = 540, Class III = 90 µg/person/day. 
3) Procedure path A substances can be predicted to be metabolised to innocuous products.  Procedure path B substances cannot. 
4) No safety concern based on intake calculated by the MSDI approach of the named compound. 
5) Data must be available on the substance or closely related substances to perform a safety evaluation. 
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TABLE 3: QSAR PREDICTIONS ON MUTAGENICITY IN FIVE MODELS FOR 10 KETONES FROM SUBGROUP 4.4 
FL-no 
JECFA-no 
Sub- 
group 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
ISS Local Model 
Ames Test 
TA100 
 
MultiCASE  
Ames test 
  
MultiCASE 
Mouse 
lymphoma test 
MultiCASE 
Chromosomal 
aberration test in 
CHO 
MultiCASE 
Chromosomal 
aberration test in 
CHL 
Substances in subgroup 4.4a (Furan-3(2H)-ones) 
13.089 
1451 
4.4 2,5-Dimethyl-4-methoxyfuran-3(2H)-
one 
O
OO
3664 
- 
4077-47-8 
OD* NEG OD* OD* OD* 
13.117 
 
4.4 2,5-Dimethyl-4-ethoxyfuran-3(2H)-
one 
O
OO
- 
- 
65330-49-6 
OD* NEG OD* OD* OD* 
13.119 
 
4.4 2,5-Dimethylfuran-3(2H)-one O
O
- 
11066 
14400-67-0 
OD* NEG OD* OD* OD* 
13.157 
 
4.4 5-Methylfuran-3(2H)-one O
O
- 
- 
3511-32-8 
OD* NEG POS OD* OD* 
13.175 
 
4.4 4-Acetyl-2,5-dimethylfuran-3(2H)-
one 
O
O
O
- 
- 
- 
OD* NEG OD* OD* OD* 
Substances in subgroup 4.4b (Furan-3(2H)-ones in which the alpha,beta-unsaturated double bond can be involved in keto-enol tautomerism) 
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FL-no 
JECFA-no 
Sub- 
group 
EU Register name Structural formula FEMA no 
CoE no 
CAS no 
ISS Local Model 
Ames Test 
TA100 
 
MultiCASE  
Ames test 
  
MultiCASE 
Mouse 
lymphoma test 
MultiCASE 
Chromosomal 
aberration test in 
CHO 
MultiCASE 
Chromosomal 
aberration test in 
CHL 
13.010 
1446 
4.4 4-Hydroxy-2,5-dimethylfuran-3(2H)-
one 
O
OHO
3174 
536 
3658-77-3 
OD* NEG NEG OD* NEG 
13.084 
1449 
4.4 2-Ethyl-4-hydroxy-5-methyl-3(2H)-
furanone 
O
OHO
3623 
- 
27538-09-6 
OD* NEG NEG OD* NEG 
13.085 
1450 
4.4 4-Hydroxy-5-methylfuran-3(2H)-one O
OHO
3635 
11785 
19322-27-1 
OD* NEG NEG OD* NEG 
13.099 
1456 
4.4 4-Acetoxy-2,5-dimethylfuran-3(2H)-
one 
O
OO
O
3797 
- 
4166-20-5 
OD* NEG OD* OD* OD* 
13.176 4.4 Furaneyl butyrate O
OO
O
3970 
- 
- 
OD* NEG OD* OD* NEG 
Column 2: Structure group 4.4: α,β-unsaturated ketones.  
Column 6: Local model on aldehydes and ketones, Ames TA100. (NEG: Negative; POS: Positive; OD*: Out of domain). 
Column 7: MultiCase Ames test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 8: MultiCase Mouse Lymphoma test (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 9: MultiCase Chromosomal aberration in CHO (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
Column 10: MultiCase Chromosomal aberration in CHL (OD*: Out of domain; POS: Positive; NEG: Negative; EQU: Equivocal). 
* OD, out of applicability domain: not matching the range of conditions where a reliable prediction can be obtained in this model. These conditions may be physicochemical, structural, biological, etc.. 
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TABLE 4: CARCINOGENICITY STUDIES 
Table 4: Carcinogenicity Studies 
Chemical Name [FL-no]  Species; Sex 
No./Group 
Route  Dose levels Duration Results Reference Comments 
4-hydroxy-2,5-dimethylfuran-
3(2H)-one [13.010] 
Rats; Male, 
Female 
60/sex/group 
Diet 0, 100, 200, or 400 
mg/kg bw/day 
2 years Males: No increase in tumour 
incidences 
Females: No increases in tumour 
incidences 
(Kelly & Bolte, 2003) 
 
Valid (GLP/OECD compliant). 
The NOAEL was 200  mg/kg bw/day 
based on  reduced mean body weight at 
the highest dose. 
TABLE 5: GENOTOXICITY (IN VITRO) 
Table 5: GENOTOXICITY (in vitro) 
Chemical Name [FL-no]  Test System Test Object  Concentration Reported 
Result  
Reference  Comments e
4-hydroxy-2,5-dimethylfuran-
3(2H)-one [13.010] 
Reversed mutation S. typhimurium TA1535, TA1537, 
TA1538,TA100 and TA98 
10.0, 33.3, 100.0, 333.3, 1000, 
2000, 3300, 4000, 6000, 8000 
µg/plate 
Positivea, b (Gilroy et al., 1978) 
 
Valid. Unpublished non-GLP study. The 
report contains sufficient details. Result is 
considered valid. 
Reversed mutation S. typhimurium TA100 and TA98 0 – 10000 µg/plate Positivea, b (Hiramoto et al., 
1996b) 
 
Valid. Positive in TA 100 + and – S9; 
negative in TA 98 (+/- S9). 
Reversed mutation S. typhimurium TA100, TA102, 
TA98 and TA97 
500 – 4000 µg/plate Positivea, c (Xing et al., 1988) 
 
Limited validity. No methodological details, 
but stated to be performed according to 
(Maron & Ames, 1983). Some  errors reduce 
the trustworthiness of the paper. 
Reversed mutation E. coli WP2 uvrA- 10.0, 33.3, 100.0, 333.3, 1000, 
3300 µg/plate 
Negative (Gilroy et al., 1978) 
 
Valid. Unpublished non-GLP study. The 
report contains sufficient details. Result is 
considered valid. 
DNA damage  B. subtilis H17 (Rec+) and M45 
(Rec-) 
20, 40, 60, 80, 120 µg/disc Positive (Xing et al., 1988) 
 
Validity cannot be evaluated (Test system 
with low predictive value for genotoxicity).  
No methodological details, but stated to be 
performed according to (Kada et al., 1972). 
DNA strand breaks  pBR322 DNA 2.6 – 780 µmol/l 
(0.3 – 100 mg/l) 
Positive (Hiramoto et al., 
1996b) 
 
Valid. Single strand breaks caused by redox 
cycling of the substance in combination with 
metal ions, generating Reactive oxygen 
species. 
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Table 5: GENOTOXICITY (in vitro) 
Chemical Name [FL-no]  Test System Test Object  Concentration Reported 
Result  
Reference  Comments e
4-Hydroxy-5-methylfuran-
3(2H)-one [13.085] 
 
Reversed mutation S. typhimurium TA100 and TA98 0 – 5000 µg/plate Positivea, b (Hiramoto et al., 
1996a) 
 
Limited validity. Limited due to uncertainty 
of test substance. Positive in TA 100 + and – 
S9; negative in TA 98 (+/- S9). 
4-Hydroxy-5-methylfuran-
3(2H)-one [13.085] cont. 
 
DNA strand breaks  pBR322 DNA 0 -900 µmol/l 
(0 – 103mg/l) 
Positivea, d (Hiramoto et al., 
1996a) 
 
Valid. Single strand breaks caused by redox 
cycling of the substance in combination with 
metal ions, generating reactive oxygen 
species. 
2,5-Dimethyl-3(2H)-Furanone 
[13.119] 
Reverse mutation S. typhimurium TA1535, TA1537, 
TA98,TA100 and TA102,  
0 – 5000 µg/plate Negative (RCC - CCR, 2007) 
 
Valid. According to current guidelines. 
2-ethyl-4-hydroxy-5-methyl-
3(2H)-furanone [13.084] 
Reversed mutation S. typhimurium TA100 and TA98 0 – 10000 µg/plate Positivea, b (Li et al., 1998) 
 
 Valid. + with and without S9 in TA 100; 
negative in TA98 (+/- S9). 
DNA strand breaks pBR322 DNA 0-2000 μM Positived (Li et al., 1998) 
 
Valid. Single strand breaks caused by redox 
cycling of the substance in combination with 
metal ions, generating reactive oxygen 
species. 
a: With and without metabolic activation provided by S9 (9000 x g supernatant from rodent liver). 
b: Positive results only observed in TA100. 
c: Positive results in all strains at the highest dose tested. 
d: Only positive without inhibitors of redox cycling and ROS scavengers. 
e: Validity of genotoxicity studies: 
 Valid. 
 Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation). 
 Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
 Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
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TABLE 6: GENOTOXICITY (IN VIVO) 
Table 6: GENOTOXICITY (in vivo) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Reported Result  Reference  Comments a 
4-hydroxy-2,5-dimethylfuran-
3(2H)-one [13.010] 
Micronucleus 
formation 
Mouse, bone 
marrow 
Not stated 0, 186, 232 or 309 mg/kg 
bw 
Positive (Xing et al., 1988) 
 
Limited validity. Important 
data not given. Reference to 
methodological description 
could not be traced. 
Chromosomal 
aberration 
Mouse 
spermatocytes 
Not stated 0, 232, 464 or 928 mg/kg 
bw 
Positive (Xing et al., 1988) Limited validity. Important 
data not given. Reference to 
methodological description 
could not be traced. 
Predominant aberration: 
malsegregation of 
chromosomes. 
Sister chromatid 
exchange 
Mouse, bone 
marrow 
Intra-abdominal 
injection 
0, 185, 232, 303 mg/kg Positive (Xing et al., 1988) Validity cannot be assessed. 
Dose-related increase; 
statistically significant at all 
dose levels, but max increase < 
2-fold. Effect not adequately 
specified; very intense 
exposure to BrdU.  Non-
validated protocol. Relevance 
for the evaluation of 
genotoxicity questionable. 
Sister chromatid 
exchange 
Mouse 
spermatocytes 
Oral (gavage) 200, 400 or 800 mg/kg 
bw 
Positive (Tian et al., 1992) 
 
Limited validity. Relevance for 
the evaluation of genotoxicity 
questionable; non- validated 
test protocol. 
Micronucleus 
formation 
Mouse early sperm 
cells 
Oral (gavage) 200, 400 or 800 mg/kg 
bw 
Positive (Tian et al., 1992) 
 
Limited validity. Non-
validated test protocol. 
Micronucleus 
formation 
Mouse peripheral 
blood cells 
Gavage 1000, 2000 
3000 mg/kg bw 
Positive (Hiramoto et al., 1998) 
 
Valid. 
Micronucleus 
formation 
Male mice 
peripheral 
erythrocytes 
i.p. 500, 1000, 1500mg/kg 
bw 
Positive (Hiramoto et al., 1996b) 
 
Valid. 
2-ethyl-4-hydroxy-5-methyl- Micronucleus Mouse peripheral Gavage 0, 1000, 2000, and 3000 Positive (Hiramoto et al., 1998) Valid. 
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Table 6: GENOTOXICITY (in vivo) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Reported Result  Reference  Comments a 
3(2H)-furanone [13.084] formation blood cells mg/kg bw   
Micronucleus 
formation 
Male mice 
peripheral 
erythrocytes 
i.p. 0, 500 and 1000 mg/kg 
bw 
Positive (Li et al., 1998) 
 
Valid. 
a: Validity of genotoxicity studies: 
 Valid. 
 Limited validity (e.g. if certain aspects are not in accordance with OECD guidelines or current standards and / or limited documentation). 
 Insufficient validity (e.g. if main aspects are not in accordance with any recognised guidelines (e.g. OECD) or current standards and/or inappropriate  test system). 
 Validity cannot be evaluated (e.g. insufficient documentation, short abstract only, too little experimental details provided). 
 
TABLE 7: SUMMARY OF ADDITIONAL GENOTOXICITY DATA ON 4-HYDROXY-2,5-DIMETHYLFURAN-3(2H)-ONE SUBMITTED BY INDUSTRY 
Table 7: GENOTOXICITY (in vitro and in vivo) 
Chemical Name [FL-no]  Test System Test Object  Route Dose Reported Result  Reference  Comments a
4-hydroxy-2,5-dimethylfuran-
3(2H)-one [13.010] 
Mouse Lymphoma L5178Ytk+/- 
mouse lymphoma 
cells 
- 111, 167, 250, 375 and 
750 micrograms/ml 
Negative both with and 
without S9 
(Ross & Harris, 1979a) Limited validity.  
Study not performed according to 
current guideline. Too short 
treatment and no differentiation 
between small and large colonies. 
 
Dominant lethal assay 
in a rat fertility study 
Dominant lethals in 
Crl:CD(SD) male 
rats (25/group) 
Oral gavage 100, 500 and 1000 mg/kg 
bw/day for 2 
weeks(Phase I) and 9 
weeks (Phase II) 
No increase of dominant 
lethal effects 
(Sloter, 2008) Valid GLP study in accordance 
with ICH Guideline 4.1.1. 
 
A study by Honarvar (Honarvar, 2008b) was also submitted. However due to unknown identity of the tested material, this study is not included in the table.
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ABBREVIATIONS 
ADI  Acceptable Daily Intake 
BW  Body Weight 
CAS  Chemical Abstract Service 
CEF Panel on Food Contact Materials, Enzymes, Flavourings and Processing Aids 
Chemical Abstract Service 
CHO  Chinese Hamster Ovary (cells) 
CHL  Chinese Hamster Lung (cells) 
CoE  Council of Europe 
DNA  Deoxyribonucleic acid 
EC European Commission 
EFFA  European Flavour and Fragrance Association 
EFSA  The European Food Safety Authority 
EU  European Union 
FAO  Food and Agriculture Organization of the United Nations  
FEMA  Flavor and Extract Manufacturers Association 
FGE  Flavouring Group Evaluation  
FLAVIS (FL) Flavour Information System (database) 
GLP  Good Laboratory Practice 
ICH  International Conference on Harmonisation 
ID   Identity 
IOFI  International Organization of the Flavour Industry 
IR   Infrared spectroscopy 
JECFA  The Joint FAO/WHO Expert Committee on Food Additives 
LD50  Lethal Dose, 50%; Median lethal dose 
MS  Mass spectrometry 
MSDI  Maximised Survey-derived Daily Intake 
mTAMDI Modified Theoretical Added Maximum Daily Intake 
NAD  Nicotinamide Adenine Dinucleotide  
NADP  Nicotinamide Adenine Dinucleotide Phosphate 
No  Number 
NOAEL No Observed Adverse Effect Level 
NOEL  No Observed Effect Level 
NTP  National Toxicology Program 
QSAR  Quantitative Structure-Activity Relationship 
SCE  Sister Chromatid Exchange 
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SCF  Scientific Committee on Food 
SMART  Somatic Mutation and Recombination Test  
TAMDI Theoretical Added Maximum Daily Intake 
UDS  Unscheduled DNA Synthesis  
WHO  World Health Organisation  
